Mixed Mode Chromatography Resin Market
Report ID: SQMIG35J2424
Report ID: SQMIG35J2424
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35J2424 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
91
|Figures:
76
Global Mixed Mode Chromatography Resin Market size was valued at USD 117.5 Million in 2024 and is poised to grow from USD 131.95 Million in 2025 to USD 333.78 Million by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).
Rising demand for biopharmaceuticals, increasing development of monoclonal antibodies and gene therapies, rising focus on improving downstream processing efficiency, advancements in chromatography technologies, and expanding biologics manufacturing capacity are driving sales of mixed mode chromatography resins.
Increased complexity of biologic drugs and rising demand for high-purity biopharmaceutical products are expected to primarily drive mixed mode chromatography resin market growth. Ongoing investments in the development and large-scale commercial production of biotherapeutics are helping to drive the bioprocessing market toward growth. However, development of continuous bioprocessing and newer downstream manufacturing platform are another key trend that is contributing to a growing market. Mixed mode chromatography resins allow bioprocessors to perform both capture and polishing steps within a single step of a process, which reduces processing costs, improves yields and shortening the processing time required for separation. Because biopharmaceutical companies need more manufacturing efficiencies and rapid time to market, highly selective and durable chromatography media continue to grow. Increased development of gene therapy, cell therapy and antibody-drug conjugates has been driving the need for specialized purification platforms capable of performing these complex separations. In order to promote adoption of continuous bioprocessing, development of the next generation purification platforms is a topic that is being explored between resin manufacturers, CDMOs, and biopharmaceutical companies, with widespread adoption continuing in countries around the globe.
However, high resin costs, complex process development requirements, limited reusability in certain applications, and availability of alternative purification technologies are anticipated to slow down mixed mode chromatography resin market penetration across the study period and beyond.
How is AI Improving Process Optimization In The Mixed Mode Chromatography Resin Market?
Mixed mode chromatography resins use combinations of multiple modes of interaction for improved separation efficiency of complex biomolecules. The application of AI is making mixed mode resins more effective for manufacturers to better control their purification processes, develop processes faster, and enhance process reproducibility. Researchers can use AI to make more informed decisions and limit the need for trial and error in process development. Digital twins and complex AI models can model and predict how purification processes and elution profiles will be shaped and to pinpoint potential foul-prone spots before large-scale runs can begin. This can then be used to refine buffer conditions, enhance the properties of the mixed mode resin and increase product recovery yields, all of which can be translated into smarter resin choices, quicker process development and a more resilient manufacturing workflow that ultimately makes mixed mode resins much more compelling choices for downstream processing and production of commercial biologics.
Market snapshot - (2026-2033)
Global Market Size
USD 117.5 Million
Largest Segment
Ion Exchange Mixed Mode
Fastest Growth
Hydrophobic Interaction Mixed Mode
Growth Rate
12.3% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global mixed mode chromatography resin market is segmented by resin type, application, end-user, and region. Based on resin type, the market is segmented into ion exchange mixed mode, hydrophobic interaction mixed mode, and others. Based on application, the market is segmented into antibody purification, protein purification, vaccine manufacturing, and others. Based on end-user, the market is segmented into pharmaceutical and biopharmaceutical companies, academic and research institutes, and contract research organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The ion exchange mixed mode segment is slated to account for the highest global mixed mode chroatography resin market share going forward. The combined binding chemistries provide a strong capture and polish purification workflow for multiple biomolecule targets, increasing selectivity and yield and minimizing the number of process steps. Such an improvement in performance has led to rapid acceptance by developers desiring robust and scalable purification platform technology; as this technology is compatible with existing systems, will behave consistently, thus reducing development risk and enabling faster time to clinic, it will be in demand and solidify its leader position.
However, hydrophobic interaction mixed mode is emerging as the most rapidly expanding segment driven by both the increasing requirement for gentle purification of intricate proteins and aggregates, and novel ligand chemistries with improved selectivity, coupled with interest in integrated capture workflows. Both have the effect of extending the application field to fragile biologics and drive process intensification opportunities, thus stimulating the speed of the market growth.
The antibody purification segment is expected to lead the global mixed mode chroatography resin market revenue generation across the study period. Addressing the demands for purity, yield and heterogeneity intrinsic antibody capture and polishing; mixed mode resin platform can ensure the highly efficient clearance of host cell proteins and difficult variants. The broad industry attention on mAb therapeutics and biosimilars ensures the ongoing investment into scalable and high-resolution chemistries and the low risk in terms of scale up and regulatory familiarization will support the current application to be the largest demand driver.
Meanwhile, vaccine manufacturing is emerging as the fastest growing application segment as per this mixed mode chroatography resin market forecast, driven by broadening vaccine platforms, increased attention on the process economy and high throughput purification, and a requirement for resins that work with virus vectors and nanoparticle-based formulations. The investment in the tailored mixed mode chemistries coupled with regulatory driving forces on process economy is expediting market opportunities and growth.
To get detailed segments analysis, Request a Free Sample Report
Advanced research infrastructure, a dense concentration of pharmaceutical and biotechnology firms, and a mature diagnostics industry are helping this region hold sway over others. In addition, a strong regulatory environment and well-established quality programs promote the use of new resin technologies while large companies provide funding for process development and scale up. Access to top academic institutions help speed up technology transfer and joint development. Extensive distribution channels and experienced service providers enable rapid deployment. Local manufacturers develop new products continuously and provide tailored technical support to reinforce their position as market leaders. There is also a strong partnership between industry and academia providing early-stage commercialization.
Mixed Mode Chromatography Resin Market United States benefits from a deep concentration of pharmaceutical development activity and an ecosystem of specialized resin manufacturers and service providers. Laboratory infrastructure and contract development organizations enable rapid method optimization and scale up. High demand from biologics development and bioprocessing drives innovation and customized solutions, while strong ties between industry and research institutions accelerate application development and commercial adoption across therapeutic and diagnostic segments.
Mixed mode chromatography resin demand in Canada combines a robust research base with expanding contract testing and bioprocessing capabilities. Manufacturers will provide targeted resin chemistries and assistance, which will lead to customized separations for more difficult molecules. Collaboration between research labs and industry will provide new methods and validation of these techniques. Activities in this space are driven by suppliers, who will help provide newer chemistries, thus enabling domestic developers and biotechs to use mixed modes in their analytical development activities.
Concentrated life sciences clusters, established pharmaceutical manufacturing capacity, and increasing adoption of platform technologies for complex separations support high mixed mode chroatography resin demand in Europe. Contract research and contract manufacturing organizations throughout Europe have implemented mixed-mode approaches in their plant processes to increase purification productivity and analytical resolution; this has increased the demand for new, versatile resin chemistries. Regulatory requirements such as emphasis on product quality and process reproducibility encourage the use of industry proven separation technologies. Manufacturers and specialty chemical companies are also investing in customized solutions and technical service capability that address the varying national needs of these markets. Collaborative, cross border efforts between various academic institutions, technology providers, and industrial participants are effectively speeding up the transfer of analytical and process methods to commercial production. The combination of these ingredients; outstanding technical talent, extensive local support networks and collaborative efforts to accelerate the transfer of analytical and production methods uniquely position Europe as one of the fastest-growing regions for mixed-mode chromatography technology solutions.
Demand for mixed mode chroatography resin in Germany benefits from deep industrial expertise in pharmaceutical production and specialized chemical manufacturing that supports resin development and application. With good engineering and process chemistry infrastructure in place the mix mode solution can be integrated in the downstream process and analytical functions. Method development and validation are in partnership with technical universities and industry. Established supply chain and service providers allow both local manufactures and multinationals use the technology for challenging separation tasks.
Mixed Mode Chromatography Resin adoption in the United Kingdom features dynamic life sciences clusters and a growing community of biotech firms and contract organizations adopting advanced separation technologies. Translational research and commercialization support accelerate uptake of novel resin chemistries. Technical service providers and flexible manufacturing networks enable rapid implementation. Market momentum is reinforced by industry university partnerships that create a receptive environment for mixed mode solutions across analytical development and bioprocess purification.
Sales of mixed mode chroatography resin products in France are emerging as research centers and biotech clusters adopt advanced separation methods. Both the contract organization and university research laboratory utilize mixed modes for complicated molecule analysis and purification. A private domestic chemical company develops custom resins and services based on industry needs. Together the government research institute and private company can collaborate in method transfer and scale up, so the domestic pharmaceutical and bioprocess market is ready to use such applications.
High investments in biopharmaceutical research, growing contract development and manufacturing activity, and rising technical expertise in separation sciences are creating high mixed mode chromatography resin demand in the region. Local biopharmaceutical companies are increasingly employing mixed-mode technologies in their research and development and production processes for analytical and preparative applications. In addition to mixed-mode technologies, local manufacturers are expanding their technical assistance and customizing services to ensure that they meet the increasingly diverse processing needs of their customers. There are many strong industrial ecosystems in key markets within the region that have developed to support continued collaboration between academia, specialty chemical companies, and bioprocessing organizations. The result of this collaboration is the rapid evaluation of method development and commercializing new products within the region. In addition to the focus on production efficiencies and the movement toward platform approaches, there has been significant activity surrounding the incorporation of mixed mode resin technologies into downstream processes. These strategic partnerships provide local manufacturers with access to advanced chemistries and extensive manufacturing expertise, thereby increasing product availability and support after the sale of a product.
Mixed mode chromatography resin demand in Japan benefits from advanced manufacturing capabilities and a tradition in precision chemical development, supporting specialized resin formulation and consistent product quality. Pharmaceutical research and diagnostics requires a good separation technology. Contract organizations co-operate with academic groups in the method development. Local distributors and service teams help with the application support and customization. The market requires good quality and reliability, which ensures the use in analytical and production purposes.
Mixed Mode Chromatography Resin Market South Korea is advancing through a strong biomanufacturing base and contract development organizations that adopt advanced separation strategies. Local chemical firms develop customized resin chemistries and provide technical service for method optimization. Collaboration among universities and industry providers accelerates translation of laboratory methods into production workflows. Emphasis on manufacturing efficiency and integration with process platforms supports broader uptake in analytical development and downstream purification activities.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Biopharmaceutical Manufacturing
Innovation In Resin Chemistry
High Production And Material Costs
Regulatory Compliance And Validation
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global mixed mode chromatography resin market is intensifying as incumbents and deep-tech startups pursue process intensification and single use solutions. Established suppliers introduce new mixed mode formats such as Bio-Rad's Nuvia series. Consolidation is visible in deals like Gamma Biosciences' acquisition of Nanopareil, while innovators such as Lumatix commercialize cellulose monolith and light controlled affinity alternatives.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, increasing development of monoclonal antibodies and gene therapies, rising focus on improving downstream processing efficiency, advancements in chromatography technologies, and expanding biologics manufacturing capacity are anticipated to drive the demand for mixed mode chromatography resins going forward. However, high resin costs, complex process development requirements, limited reusability in certain applications, and availability of alternative purification technologies are slated to slow down the adoption of mixed mode chromatography resins in the future. North America is slated to spearhead the demand for mixed mode chromatography resins owing to the presence of a strong biopharmaceutical industry, high investments in biologics and gene therapy development, advanced manufacturing infrastructure, and increasing adoption of continuous bioprocessing technologies. Development of AI-driven process optimization platforms, integration of digital twin technologies in downstream processing, and increasing adoption of continuous and single-use chromatography systems are anticipated to be key trends driving the mixed mode chromatography resin sector over the coming years.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 117.5 Million |
| Market size value in 2033 | USD 333.78 Million |
| Growth Rate | 12.3% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Mixed Mode Chromatography Resin Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Mixed Mode Chromatography Resin Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Mixed Mode Chromatography Resin Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Mixed Mode Chromatography Resin Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Mixed Mode Chromatography Resin Market size was valued at USD 117.5 Million in 2024 and is poised to grow from USD 131.95 Million in 2025 to USD 333.78 Million by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).
Competition in the global mixed mode chromatography resin market is intensifying as incumbents and deep-tech startups pursue process intensification and single use solutions. Established suppliers introduce new mixed mode formats such as Bio-Rad's Nuvia series. Consolidation is visible in deals like Gamma Biosciences' acquisition of Nanopareil, while innovators such as Lumatix commercialize cellulose monolith and light controlled affinity alternatives. 'Danaher', 'Sartorius', 'Merck KGaA', 'Thermo Fisher Scientific', 'Repligen Corporation', 'Bio-Rad Laboratories', 'GE Healthcare', 'Tosoh Corporation', 'Purolite', 'Agilent Technologies', 'Waters Corporation', 'Kaneka Corporation', 'Mitsubishi Chemical Group', 'JSR Corporation', 'YMC Company', 'Sepax Technologies', 'Novasep', 'ChromaCon', 'Linde', 'Shimadzu Corporation'
Growing biopharmaceutical manufacturing expands the need for versatile purification platforms capable of handling diverse molecular properties, and mixed mode chromatography resins offer combined interaction mechanisms that simplify separations. As manufacturers pursue higher product purity and stronger process robustness, these resins provide adaptable selectivity and reduce the number of processing steps, which streamlines workflows and conserves developmental resources. This capability encourages adoption across contract developers and manufacturers seeking reliable, flexible purification solutions, thereby directly supporting market expansion through increased procurement and method integration.
Adoption For Complex Biologics: Manufacturers of therapeutic proteins, antibody derivatives and biologics are adopting mixed-mode resins to address heterogeneity and challenging separations. Their multifunctional binding characteristics enhance selectivity across diverse charge and hydrophobic profiles, enabling streamlined purification strategies with fewer polishing steps. This trend is driven by demand for flexible platforms that accommodate molecule complexity, shorten development cycles, enabling platform transfer across manufacturing scales. Suppliers are responding with tailored chemistries and formats emphasizing robustness, scalability and compatibility with modern purification workflows, strengthening biopharma adoption.
Why does North America Dominate the Global Mixed Mode Chromatography Resin Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
